A carregar...
A randomized open-label trial on the use of budesonide/formoterol (Symbicort(®)) as an alternative reliever medication for mild to moderate asthmatic attacks
BACKGROUND: Conventionally, a nebulized short-acting β-2 agonist like salbutamol is often used as the reliever in acute exacerbations of asthma. However, recent worldwide respiratory outbreaks discourage routine use of nebulization. Previous studies have shown that combined budesonide/formoterol (Sy...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3352303/ https://ncbi.nlm.nih.gov/pubmed/22503137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1865-1380-5-16 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|